By expenditures
| Name | Title | Type |
|---|---|---|
| Rick Vincent | Executive Vice President and Chief Financial Officer | Auditee |
| Jessica Liconti | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 339776 | 2024 | 2025-01-24 | Ernst & Young | $25.56M |
| 306487 | 2023 | 2024-05-16 | Ernst & Young LLP | $67.81M |
| 55778 | 2022 | 2023-06-29 | Ernst & Young LLP | $57.50M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 339776 | 2024 | 2025-01-24 | 1096662 | 2024-001 | Material Weakness | - | P |
| 339776 | 2024 | 2025-01-24 | 1096661 | 2024-001 | Material Weakness | - | P |
| 339776 | 2024 | 2025-01-24 | 520220 | 2024-001 | Material Weakness | - | P |
| 339776 | 2024 | 2025-01-24 | 520219 | 2024-001 | Material Weakness | - | P |
| 306487 | 2023 | 2024-05-16 | 973509 | 2023-001 | Significant Deficiency | - | L |
| 306487 | 2023 | 2024-05-16 | 397067 | 2023-001 | Significant Deficiency | - | L |
| 55778 | 2022 | 2023-06-29 | 636131 | 2022-001 | Significant Deficiency | - | AB |
| 55778 | 2022 | 2023-06-29 | 636130 | 2022-002 | Material Weakness | - | P |
| 55778 | 2022 | 2023-06-29 | 59689 | 2022-001 | Significant Deficiency | - | AB |
| 55778 | 2022 | 2023-06-29 | 59688 | 2022-002 | Material Weakness | - | P |